Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
- PMID: 32304612
- PMCID: PMC7264504
- DOI: 10.1002/uog.22049
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic
Comment in
-
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?Ultrasound Obstet Gynecol. 2020 Jun;55(6):843-844. doi: 10.1002/uog.22063. Ultrasound Obstet Gynecol. 2020. PMID: 32349165 Free PMC article. No abstract available.
Comment on
-
An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805. doi: 10.5858/arpa.2020-0901-SA. Arch Pathol Lab Med. 2020. PMID: 32180426 Review.
References
-
- Mullins E, Evans D, Viner RM, O'Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 2020; 55: 586–592. - PubMed
-
- Day M. Covid‐19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020; 368: m1086. - PubMed
-
- Voiriot G, Chalumeau M, Messika J, Basille D, Philippe B, Ricard JD, Andrejak C, Jounieaux V, Sanchez O, Fartoukh M. [Risks associated with the use of non‐steroidal anti‐inflammatory drugs during pneumonia]. Rev Mal Respir 2018; 35: 430–440. - PubMed
-
- FitzGerald GA. Misguided drug advice for COVID‐19. Science 2020; 367: 1434. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources